For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

Glenn Tullman, the CEO of Transcarent, is taking another big shot at transforming the U.S. health care system.

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

Find out in our full research report, it’s free. Formerly known as Anthem until its 2022 rebranding, Elevance Health (NYSE:ELV) is one of America's largest health insurers, serving approximately ...

Over 90,000 patients face difficult decisions after Anthem Blue Cross Blue Shield and MU Health Care didn't reach a deal.

Elevance Health (ELV) stock slips amid pressure from UnitedHealth's (UNH) Q1 results, even as its own early Q1 2025 results ...

With a market cap of $102.5 billion, Elevance Health, Inc. (ELV) is a health benefits company offering a wide range of medical, pharmacy, and healthcare services across its four segments: Health ...

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. The company expects ...

Shares of Apple and Tesla have lost more than 10% since “Liberation Day” during the stock market rollercoaster.

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

In a regulatory filing, Elevance Health (ELV) noted it will release its first quarter 2025 financial results on April 22. “First quarter ...